- BAK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $10.9 million.
- BAK traded 103,700 shares today in the pre-market hours as of 9:01 AM, representing 14.2% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in BAK with the Ticky from Trade-Ideas. See the FREE profile for BAK NOW at Trade-Ideas More details on BAK: Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The stock currently has a dividend yield of 3.4%. Currently there is 1 analyst that rates Braskem a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Braskem has been 497,100 shares per day over the past 30 days. Braskem has a market cap of $5.9 billion and is part of the basic materials sector and chemicals industry. Shares are down 16.2% year-to-date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates Braskem as a hold. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, good cash flow from operations and notable return on equity. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and poor profit margins. Highlights from the ratings report include:
- Net operating cash flow has significantly increased by 360.95% to $389.24 million when compared to the same quarter last year. In addition, BRASKEM SA has also vastly surpassed the industry average cash flow growth rate of 11.80%.
- The revenue fell significantly faster than the industry average of 9.8%. Since the same quarter one year prior, revenues fell by 23.1%. Weakness in the company's revenue seems to have hurt the bottom line, decreasing earnings per share.
- The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Chemicals industry. The net income has significantly decreased by 52.3% when compared to the same quarter one year ago, falling from $179.33 million to $85.58 million.
- The debt-to-equity ratio is very high at 3.58 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company. Along with the unfavorable debt-to-equity ratio, BAK maintains a poor quick ratio of 0.76, which illustrates the inability to avoid short-term cash problems.
- You can view the full Braskem Ratings Report.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.